North Star Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $48.7K | Buy |
385
+136
| +55% | +$17.9K | ﹤0.01% | 750 |
|
|
2026
Q1 | $34.7K | Buy |
249
+6
| +2% | +$840 | ﹤0.01% | 812 |
|
|
2025
Q4 | $29.9K | Buy |
243
+86
| +55% | +$10.5K | ﹤0.01% | 777 |
|
|
2025
Q3 | $17.5K | Buy |
157
+5
| +3% | +$568 | ﹤0.01% | 829 |
|
|
2025
Q2 | $16.9K | Buy |
152
+1
| +0.7% | +$106 | ﹤0.01% | 813 |
|
|
2025
Q1 | $17K | Sell |
151
-75
| -33% | -$7.74K | ﹤0.01% | 782 |
|
|
2024
Q4 | $20.9K | Sell |
226
-169
| -43% | -$15.2K | ﹤0.01% | 753 |
|
|
2024
Q3 | $33.1K | Buy |
395
+47
| +14% | +$3.59K | ﹤0.01% | 663 |
|
|
2024
Q2 | $23.9K | Sell |
348
-540
| -61% | -$36K | ﹤0.01% | 693 |
|
|
2024
Q1 | $65K | Buy |
888
+4
| +0.5% | +$308 | ﹤0.01% | 571 |
|
|
2023
Q4 | $71.6K | Buy |
884
+1
| +0.1% | +$78 | 0.01% | 539 |
|
|
2023
Q3 | $66.2K | Buy |
883
+22
| +3% | +$1.69K | 0.01% | 547 |
|
|
2023
Q2 | $66.4K | Buy |
861
+1
| +0.1% | +$80 | 0.01% | 562 |
|
|
2023
Q1 | $71.4K | Buy |
860
+1
| +0.1% | +$83 | 0.01% | 565 |
|
|
2022
Q4 | $73.7K | Buy |
859
+193
| +29% | +$15.3K | 0.01% | 534 |
|
|
2022
Q3 | $41K | Buy |
666
+2
| +0.3% | +$126 | ﹤0.01% | 574 |
|
|
2022
Q2 | $41K | Buy |
664
+1
| +0.2% | +$62 | ﹤0.01% | 586 |
|
|
2022
Q1 | $39K | Sell |
663
-711
| -52% | -$45.4K | ﹤0.01% | 632 |
|
|
2021
Q4 | $100K | Sell |
1,374
-316
| -19% | -$21.8K | 0.01% | 483 |
|
|
2021
Q3 | $118K | Buy |
1,690
+1
| +0.1% | +$70 | 0.01% | 448 |
|
|
2021
Q2 | $116K | Buy |
1,689
+101
| +6% | +$6.74K | 0.01% | 457 |
|
|
2021
Q1 | $103K | Buy |
1,588
+669
| +73% | +$43.1K | 0.01% | 446 |
|
|
2020
Q4 | $54K | Sell |
919
-23,247
| -96% | -$1.4M | 0.01% | 523 |
|
|
2020
Q3 | $1.53M | Buy |
24,166
+5,846
| +32% | +$405K | 0.18% | 130 |
|
|
2020
Q2 | $1.41M | Buy |
18,320
+16,755
| +1,071% | +$1.28M | 0.18% | 132 |
|
|
2020
Q1 | $117K | Sell |
1,565
-23,997
| -94% | -$1.66M | 0.02% | 378 |
|
|
2019
Q4 | $1.66M | Buy |
25,562
+24,002
| +1,539% | +$1.56M | 0.17% | 144 |
|
|
2019
Q3 | $99K | Buy |
+1,560
| New | +$102K | 0.01% | 428 |
|
|
2019
Q2 | – | Sell |
-2,208
| Closed | -$144K | – | 597 |
|
|
2019
Q1 | $144K | Buy |
2,208
+9
| +0.4% | +$598 | 0.02% | 394 |
|
|
2018
Q4 | $138K | Buy |
2,199
+226
| +11% | +$15.8K | 0.02% | 374 |
|
|
2018
Q3 | $152K | Sell |
1,973
-58
| -3% | -$4.38K | 0.02% | 381 |
|
|
2018
Q2 | $144K | Buy |
2,031
+6
| +0.3% | +$424 | 0.02% | 395 |
|
|
2018
Q1 | $153K | Buy |
2,025
+939
| +86% | +$74.6K | 0.02% | 383 |
|
|
2017
Q4 | $78K | Sell |
1,086
-81
| -7% | -$6.15K | 0.01% | 474 |
|
|
2017
Q3 | $95K | Buy |
1,167
+87
| +8% | +$6.65K | 0.01% | 438 |
|
|
2017
Q2 | $76K | Sell |
1,080
-177
| -14% | -$11.8K | 0.01% | 464 |
|
|
2017
Q1 | $85K | Buy |
1,257
+280
| +29% | +$19.7K | 0.01% | 444 |
|
|
2016
Q4 | $70K | Sell |
977
-597
| -38% | -$44.4K | 0.01% | 444 |
|
|
2016
Q3 | $124K | Sell |
1,574
-591
| -27% | -$48K | 0.02% | 322 |
|
|
2016
Q2 | $181K | Buy |
2,165
+700
| +48% | +$62.1K | 0.03% | 292 |
|
|
2016
Q1 | $135K | Buy |
1,465
+54
| +4% | +$4.87K | 0.03% | 306 |
|
|
2015
Q4 | $143K | Hold |
1,411
| – | – | 0.03% | 312 |
|
|
2015
Q3 | $139K | Buy |
1,411
+895
| +173% | +$99.4K | 0.03% | 306 |
|
|
2015
Q2 | $60K | Hold |
516
| – | – | 0.01% | 378 |
|
|
2015
Q1 | $51K | Hold |
516
| – | – | 0.01% | 379 |
|
|
2014
Q4 | $49K | Buy |
516
+100
| +24% | +$10.3K | 0.01% | 379 |
|
|
2014
Q3 | $44K | Hold |
416
| – | – | 0.01% | 380 |
|
|
2014
Q2 | $34K | Hold |
416
| – | – | 0.01% | 425 |
|
|
2014
Q1 | $29K | Buy |
+416
| New | +$32.6K | 0.01% | 429 |
|
Other funds holding GILD
ECSS
North Star Investment Management's GILD Position: Q2 2026 in Review
North Star Investment Management increased its Gilead Sciences (GILD) stake by 55% in Q2 2026, buying an estimated $17.9K and bringing the position to 385 shares worth $48.7K. The position accounts for ﹤0.01% of the portfolio, ranked #750.
North Star Investment Management first reported a position in GILD in Q1 2014 and has held it in 49 quarters since. The position peaked at $1.66M in Q4 2019. 968 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- North Star Investment Management held 385 shares of Gilead Sciences worth $48.7K as of Q2 2026.
- North Star Investment Management bought 136 Gilead Sciences shares in Q2 2026, an estimated $17.9K.
- Gilead Sciences made up ﹤0.01% of North Star Investment Management's portfolio in Q2 2026, its #750 holding.
- North Star Investment Management first reported a position in Gilead Sciences in Q1 2014 and has held it in 49 quarters since.
- North Star Investment Management's Gilead Sciences position peaked at $1.66M in Q4 2019.
- 968 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on North Star Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.